Dwarfism in Mice Lacking Collagen-binding Integrins α2β1 and α11β1 Is Caused by Severely Diminished IGF-1 Levels

Autor: Ralf Hallinger, Beate Eckes, Bengt F. Belgardt, Katrin Blumbach, Thomas Krieg, Jens C. Brüning, Markus Schubert, Donald Gullberg, Markus Schmitz, Harald W.A. Ehlen, Anja Niehoff, Jan-Niklas Schulz
Rok vydání: 2012
Předmět:
musculoskeletal diseases
Male
endocrine system
congenital
hereditary
and neonatal diseases and abnormalities

Integrins
medicine.medical_specialty
Receptors
Collagen

endocrine system diseases
medicine.medical_treatment
Integrin
Medizin
Glycobiology and Extracellular Matrices
Dwarfism
Biology
Growth Hormone-Releasing Hormone
Biochemistry
Bone and Bones
Mice
Bone Density
Internal medicine
medicine
Animals
Homeostasis
Insulin-Like Growth Factor I
Receptor
Molecular Biology
Osteoblasts
Growth factor
food and beverages
Osteoblast
Cell Biology
Growth hormone–releasing hormone
medicine.disease
Mice
Mutant Strains

Extracellular Matrix
Mice
Inbred C57BL

Endocrinology
medicine.anatomical_structure
Liver
Hypothalamus
Growth Hormone
biology.protein
Female
Collagen
Integrin alpha2beta1
Signal Transduction
Hormone
Zdroj: Journal of Biological Chemistry. 287:6431-6440
ISSN: 0021-9258
DOI: 10.1074/jbc.m111.283119
Popis: Mice with a combined deficiency in the α2β1 and α11β1 integrins lack the major receptors for collagen I. These mutants are born with inconspicuous differences in size but develop dwarfism within the first 4 weeks of life. Dwarfism correlates with shorter, less mineralized and functionally weaker bones that do not result from growth plate abnormalities or osteoblast dysfunction. Besides skeletal dwarfism, internal organs are correspondingly smaller, indicating proportional dwarfism and suggesting a systemic cause for the overall size reduction. In accordance with a critical role of insulin-like growth factor (IGF)-1 in growth control and bone mineralization, circulating IGF-1 levels in the sera of mice lacking either α2β1 or α11β1 or both integrins were sharply reduced by 39%, 64%, or 81% of normal levels, respectively. Low hepatic IGF-1 production resulted from diminished growth hormone-releasing hormone expression in the hypothalamus and, subsequently, reduced growth hormone expression in the pituitary glands of these mice. These findings point out a novel role of collagen-binding integrin receptors in the control of growth hormone/IGF-1-dependent biological activities. Thus, coupling hormone secretion to extracellular matrix signaling via integrins represents a novel concept in the control of endocrine homeostasis.
Databáze: OpenAIRE